Guidelines
par
The College of Physicians and Surgeons of Newfoundland and Labrador
Date de publication
2020
Géographie
Canada
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Non
Évalué par des pairs
No
L’objectif
Provide clinical guidance to ensure the uninterrupted access to OAT medications for patients during the COVID-19 pandemic.
Constatations/points à retenir
This document provides an interim guideline for the management of OAT. It addresses office visits, remote visits, carry doses and the frequency of urine drug testing during the COVID-19 pandemic in the light of the need for social distancing, self-isolation and quarantining.
Mots clés
Clinical guidance
Harm reduction
About pharmacists
About prescribers
